Katja Weisel, MD of Janssen Oncology explains further the next steps for the POLLUX and CASTOR trials which include extending the investigation of monoclonal antibodies in front line treatments. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.
Next Steps Include Extending Investigation of Monoclonal Antibodies
